NCT02108353View on ClinicalTrials.gov

Circadian Phase Adjustment and Improvement of Metabolic Control in Night Shift Workers

PHASE3CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

March 29, 2017

Study Completion Date

March 29, 2017

Conditions
Sleep Disorders, Circadian Rhythm
Interventions
DRUG

Melatonin 2mg

once daily, 0.5-1 hours before going to bed and 1-2 hours after the last meal for 12 weeks.

DRUG

Placebo

once daily, 0.5-1 hours before going to bed and 1-2 hours after the last meal for 12 weeks.

Trial Locations (3)

20246

CTC North GmbH & Co. KG, Hamburg

52074

University Medical Center Aachen, Aachen

00133

Department of Systems Medicine, Rome

All Listed Sponsors
lead

Universitätsklinikum Hamburg-Eppendorf

OTHER

NCT02108353 - Circadian Phase Adjustment and Improvement of Metabolic Control in Night Shift Workers | Biotech Hunter | Biotech Hunter